BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 15740538)

  • 1. Easy-to-use, accurate and flexible individualized Bayesian limited sampling method without fixed time points for ciclosporin monitoring after liver transplantation.
    Langers P; Cremers SC; den Hartigh J; Rijnbeek EM; Ringers J; Lamers CB; van Hoek B
    Aliment Pharmacol Ther; 2005 Mar; 21(5):549-57. PubMed ID: 15740538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individualized population pharmacokinetic model with limited sampling for cyclosporine monitoring after liver transplantation in clinical practice.
    Langers P; Cremers SC; den Hartigh J; Rijnbeek EM; Ringers J; Lamers CB; Hommes DW; van Hoek B
    Aliment Pharmacol Ther; 2007 Nov; 26(10):1447-54. PubMed ID: 17848182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flexible limited sampling model for monitoring tacrolimus in stable patients having undergone liver transplantation with samples 4 to 6 hours after dosing is superior to trough concentration.
    Langers P; Press RR; den Hartigh J; Cremers SC; Baranski AG; Lamers CB; Hommes DW; van Hoek B
    Ther Drug Monit; 2008 Aug; 30(4):456-61. PubMed ID: 18641539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of area under the whole blood concentration versus time curve after first intravenous cyclosporine dose in children undergoing hematopoietic stem cell transplant: limited sampling strategies.
    Sibbald C; Seto W; Taylor T; Saunders EF; Doyle J; Dupuis LL
    Ther Drug Monit; 2008 Aug; 30(4):434-8. PubMed ID: 18641547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a predictive limited sampling strategy for estimation of mycophenolic acid area under the concentration time curve in patients receiving concomitant sirolimus or cyclosporine.
    Figurski MJ; Nawrocki A; Pescovitz MD; Bouw R; Shaw LM
    Ther Drug Monit; 2008 Aug; 30(4):445-55. PubMed ID: 18641543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery.
    Banner NR; David OJ; Leaver N; Davis J; Breen J; Johnston A; Yacoub MH
    Transpl Int; 2002 Dec; 15(12):649-54. PubMed ID: 12478413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limited sampling strategy for cyclosporine (Neoral) area under the curve monitoring in pediatric kidney transplant recipients.
    Strong DK; Lai A; Primmett D; White CT; Lirenman DS; Carter JE; Hurley RM; Virji M; Ensom MH
    Pediatr Transplant; 2005 Oct; 9(5):566-73. PubMed ID: 16176411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics and bayesian estimator of cyclosporine in pediatric renal transplant patients.
    Irtan S; Saint-Marcoux F; Rousseau A; Zhang D; Leroy V; Marquet P; Jacqz-Aigrain E
    Ther Drug Monit; 2007 Feb; 29(1):96-102. PubMed ID: 17304156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 3 estimation methods of mycophenolic acid AUC based on a limited sampling strategy in renal transplant patients.
    Hulin A; Blanchet B; Audard V; Barau C; Furlan V; Durrbach A; Taïeb F; Lang P; Grimbert P; Tod M
    Ther Drug Monit; 2009 Apr; 31(2):224-32. PubMed ID: 19214145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of techniques for the prediction of carboplatin exposure: application of Bayesian methods.
    Huitema AD; Mathôt RA; Tibben MM; Schellens JH; Rodenhuis S; Beijnen JH
    Clin Pharmacol Ther; 2000 Jun; 67(6):621-30. PubMed ID: 10872644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the Bayesian approach and a limited sampling model for the estimation of AUC and Cmax: a computer simulation analysis.
    Mahmood I; Miller R
    Int J Clin Pharmacol Ther; 1999 Sep; 37(9):439-45. PubMed ID: 10507242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single time point measurement by C2 or C3 is highly predictive in cyclosporine area under the curve estimation immediately after lung transplantation.
    Hangler HB; Ruttmann E; Geltner C; Bucher B; Nagiller J; Laufer G; Mueller LC
    Clin Transplant; 2008; 22(1):35-40. PubMed ID: 18217903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited sampling strategies for predicting area under the concentration-time curve of mycophenolic acid in islet transplant recipients.
    Al-Khatib M; Shapiro RJ; Partovi N; Ting LS; Levine M; Ensom MH
    Ann Pharmacother; 2010 Jan; 44(1):19-27. PubMed ID: 19996322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of ciclosporin in haematopoietic allogeneic stem cell transplantation with emphasis on limited sampling strategy.
    Wilhelm AJ; de Graaf P; Veldkamp AI; Janssen JJ; Huijgens PC; Swart EL
    Br J Clin Pharmacol; 2012 Apr; 73(4):553-63. PubMed ID: 21988410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A possible simplification for the estimation of area under the curve (AUC₀₋₁₂) of enteric-coated mycophenolate sodium in renal transplant patients receiving tacrolimus.
    Fleming DH; Mathew BS; Prasanna S; Annapandian VM; John GT
    Ther Drug Monit; 2011 Apr; 33(2):165-70. PubMed ID: 21383656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic studies of cyclosporin in Thai kidney transplantation patients.
    Kungsamrith T; Eiam-Ong S; Avihingsanon Y; Tungsanga K; Chusil S; Ayudhya DP
    J Med Assoc Thai; 2000 Nov; 83(11):1307-17. PubMed ID: 11215860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Achieving adequate cyclosporine exposure in liver transplant recipients: a novel strategy for monitoring and dosing using intravenous therapy.
    Lück R; Böger J; Kuse E; Klempnauer J; Nashan B
    Liver Transpl; 2004 May; 10(5):686-91. PubMed ID: 15108262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward better outcomes with tacrolimus therapy: population pharmacokinetics and individualized dosage prediction in adult liver transplantation.
    Staatz CE; Willis C; Taylor PJ; Lynch SV; Tett SE
    Liver Transpl; 2003 Feb; 9(2):130-7. PubMed ID: 12548506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A limited sampling strategy for estimating individual pharmacokinetic parameters of coagulation factor VIII in patients with hemophilia A.
    Bolon-Larger M; Chamouard V; Bressolle F; Boulieu R
    Ther Drug Monit; 2007 Feb; 29(1):20-6. PubMed ID: 17304146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.